Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
This study in patients with moderately to severely active Crohn's disease is designed to
establish the efficacy and safety of vedolizumab for the induction of clinical response and
remission.